Location: Del Mar, CA
CIK: 0001993440 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $536M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 372,672 | $37.51M | 7.0% | $48.11 | +58.9% | COM PAR $.01 | 457669307 |
| — | VERONA PHARMA PLC | 309,988 | $29.32M | 5.5% | $30.67 | — | SPONSORED ADS | 925050106 |
| MIRM | MIRUM PHARMACEUTICALS INC | 527,540 | $26.85M | 5.0% | $30.59 | +45.5% | COM | 604749101 |
| NUVL | NUVALENT INC | 320,798 | $24.48M | 4.6% | $69.26 | +5.6% | COM | 670703107 |
| ARGX | ARGENX SE | 43,953 | $24.23M | 4.5% | $388.36 | — | SPONSORED ADR | 04016X101 |
| BBIO | BRIDGEBIO PHARMA INC | 551,684 | $23.82M | 4.4% | $28.54 | +27.4% | COM | 10806X102 |
| ASND | ASCENDIS PHARMA A/S | 134,687 | $23.25M | 4.3% | $140.30 | — | SPONSORED ADR | 04351P101 |
| XENE | XENON PHARMACEUTICALS INC | 660,617 | $20.68M | 3.9% | $38.49 | -15.3% | COM | 98420N105 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,009,923 | $20.4M | 3.8% | $10.41 | -35.5% | COM | 68622P109 |
| NTRA | NATERA INC | 118,130 | $19.96M | 3.7% | $128.20 | +21.6% | COM | 632307104 |
| ADMA | ADMA BIOLOGICS INC | 1,092,361 | $19.89M | 3.7% | $17.93 | +13.8% | COM | 000899104 |
| ISRG | INTUITIVE SURGICAL INC | 32,305 | $17.55M | 3.3% | $449.05 | +16.4% | COM NEW | 46120E602 |
| PODD | INSULET CORP | 51,408 | $16.15M | 3.0% | $271.35 | +6.4% | COM | 45784P101 |
| TGTX | TG THERAPEUTICS INC | 447,884 | $16.12M | 3.0% | $34.03 | +9.4% | COM | 88322Q108 |
| IRON | DISC MEDICINE INC | 299,464 | $15.86M | 3.0% | $46.97 | 0.0% | COM | 254604101 |
| GH | GUARDANT HEALTH INC | 302,307 | $15.73M | 2.9% | $43.14 | +3.5% | COM | 40131M109 |
| — | MERUS N V | 292,964 | $15.41M | 2.9% | $52.59 | — | COM | N5749R100 |
| RVMD | REVOLUTION MEDICINES INC | 415,591 | $15.29M | 2.9% | $48.28 | -20.4% | COM | 76155X100 |
| AXSM | AXSOME THERAPEUTICS INC | 144,400 | $15.07M | 2.8% | $75.85 | +39.6% | COM | 05464T104 |
| BSX | BOSTON SCIENTIFIC CORP | 138,834 | $14.91M | 2.8% | $100.70 | +0.5% | COM | 101137107 |
| ACLX | ARCELLX INC | 215,223 | $14.17M | 2.6% | $62.26 | 0.0% | COMMON STOCK | 03940C100 |
| APGE | APOGEE THERAPEUTICS INC | 311,490 | $13.53M | 2.5% | $47.60 | -20.1% | COM | 03770N101 |
| RDNT | RADNET INC | 197,759 | $11.25M | 2.1% | $58.29 | -5.8% | COM | 750491102 |
| JANX | JANUX THERAPEUTICS INC | 447,420 | $10.34M | 1.9% | $50.29 | -47.6% | COM | 47103J105 |
| ELVN | ENLIVEN THERAPEUTICS INC | 509,987 | $10.23M | 1.9% | $21.53 | -12.1% | COM | 29337E102 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 521,097 | $9.437M | 1.8% | $18.24 | 0.0% | ORDINARY SHARES | N62509109 |
| HQY | HEALTHEQUITY INC | 80,880 | $8.473M | 1.6% | $93.19 | +1.7% | COM | 42226A107 |
| SPRY | ARS PHARMACEUTICALS INC | 455,953 | $7.956M | 1.5% | $11.91 | +21.2% | COM | 82835W108 |
| VERA | VERA THERAPEUTICS INC | 309,666 | $7.296M | 1.4% | $37.69 | -40.3% | CL A | 92337R101 |
| SLNO | SOLENO THERAPEUTICS INC | 86,332 | $7.233M | 1.3% | $66.03 | +13.4% | COM | 834203309 |
| HROW | HARROW INC | 228,761 | $6.986M | 1.3% | $32.60 | -17.6% | COM | 415858109 |
| — | AKERO THERAPEUTICS INC | 114,554 | $6.113M | 1.1% | $53.36 | — | COM | 00973Y108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 17,879 | $5.83M | 1.1% | $276.71 | 0.0% | COM | 02043Q107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 214,138 | $2.421M | 0.5% | $12.23 | 0.0% | COM | 483497103 |
| BBNX | BETA BIONICS INC | 157,194 | $2.289M | 0.4% | $14.16 | 0.0% | COM | 08659B102 |